Effect of topical product including Lactobacillus lysate versus placebo on the clinical symptoms in the patients with atopic dermatitis
Phase 2
- Conditions
- Atopic dermatitis.Atopic dermatitis
- Registration Number
- IRCT20120215009014N325
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Age of 18 to 60 years,
Atopic dermatitis for at least 6 months,
Involvement of at least 20% of the body surface
Exclusion Criteria
Pregnancy or breastfeeding,
Involvement of inguinal or genital area,
Bacterial infection,
Psoriasis,
Immunodeficiency disorder
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of cutaneous symptoms of atopic dermatitis. Timepoint: 2 months after the intervention. Method of measurement: with clinical examination.
- Secondary Outcome Measures
Name Time Method Sensitivity reaction due to topical cream. Timepoint: 1 and 2 months after the intervention. Method of measurement: With clinical examination.